Elvia Cowan - 23 Dec 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP, FINANCE
Signature
Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
23 Dec 2025
Net transactions value
-$556,972
Form type
4
Filing time
29 Dec 2025, 17:49:11 UTC
Previous filing
10 Sep 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cowan Elvia SVP, FINANCE C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact 29 Dec 2025 0001960048

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $235,040 -4,907 -19% $47.90 21,250 23 Dec 2025 Direct F1
transaction PCVX Common Stock Sale $321,931 -6,716 -32% $47.94 14,534 23 Dec 2025 Direct
transaction PCVX Common Stock Gift $0 -1,000 -6.9% $0.000000 13,534 23 Dec 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.
F2 Reflects the bona-fide gift of the Issuer's common stock to a Charitable Donor Advised Fund.